secwatch.observer — SEC 8-K summary
======================================

Issuer:     PharmaCyte Biotech, Inc. (PMCB)
CIK:        0001157075
Form:       8-K
Filed at:   2025-12-05T23:59:59+00:00
Accession:  0001683168-25-008947
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

PharmaCyte Biotech receives Nasdaq notice of non-compliance with $1.00 minimum bid price
--------------------------------------------------------------------------------

- Notice received Dec 1, 2025; stock closed below $1.00 for 30 consecutive business days.
- Company has 180 calendar days, until June 1, 2026, to regain compliance.
- To regain compliance, closing bid price must be at least $1.00 for 10 consecutive business days.
- If not cured by June 1, 2026, Company may seek a second 180-day period or face delisting.
- Options under consideration include a reverse stock split, subject to stockholder approval.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1157075/000168316825008947/0001683168-25-008947-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1157075/000168316825008947/pharmacyte_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-25-008947

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer